Clinical Trial

Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients

Study acronym: ABCESS2
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The study evaluates the efficacy of an adapted antibiotherapy in Hurley stage 2 active Hidradenitis Suppurativa patients versus tetracycline derivative
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-04-06; most recent amendment 2025-07-03.
Status change: Not Yet Recruiting → Recruiting 2025-07-03
Trial Details
NCT Number NCT05821478
Lead Sponsor Institut Pasteur
Collaborators: Centre Hospitalier Universitaire de Caen, Hôpital Necker-Enfants Malades, Ministry of Health, France, Assistance Publique Hopitaux De Marseille
Conditions Hidradenitis Suppurativa
Enrollment 92 participants
Start Date 2025-05-22
Primary Completion 2027-02-28 (estimated)
Study Completion 2028-02-27 (estimated)
Updated on ClinicalTrials.gov 2025-07-09